124 related articles for article (PubMed ID: 36828750)
1. Thoracic Radiation in Limited Stage Small Cell Lung Cancer: Trends in Radiation Fractionation.
Kazemi M; Ladbury C; Liu J; Glaser S; Williams T; Amini A
Clin Lung Cancer; 2023 Jun; 24(4):322-328. PubMed ID: 36828750
[TBL] [Abstract][Full Text] [Related]
2. Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
Clin Lung Cancer; 2019 Jan; 20(1):13-19. PubMed ID: 30219240
[TBL] [Abstract][Full Text] [Related]
3. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Killingberg KT; Halvorsen TO; Fløtten Ø; Brustugun OT; Langer SW; Nyman J; Hornslien K; Madebo T; Schytte T; Risum S; Tsakonas G; Engleson J; Grønberg BH
Lung Cancer; 2022 Apr; 166():49-57. PubMed ID: 35183991
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
Grønberg BH; Halvorsen TO; Fløtten Ø; Brustugun OT; Brunsvig PF; Aasebø U; Bremnes RM; Tollåli T; Hornslien K; Aksnessæther BY; Liaaen ED; Sundstrøm S;
Acta Oncol; 2016 May; 55(5):591-7. PubMed ID: 26494411
[TBL] [Abstract][Full Text] [Related]
6. Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.
Gazula A; Baldini EH; Chen A; Kozono D
Lung; 2014 Feb; 192(1):151-8. PubMed ID: 24162870
[TBL] [Abstract][Full Text] [Related]
7. Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise.
Glatzer M; Faivre-Finn C; De Ruysscher D; Widder J; Van Houtte P; Troost EGC; Dahele MR; Slotman BJ; Ramella S; Pöttgen C; Peeters STH; Nestle U; McDonald F; Le Pechoux C; Dziadziuszko R; Belderbos J; Putora PM
Radiother Oncol; 2020 Sep; 150():26-29. PubMed ID: 32447035
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
Han J; Fu C; Li B
Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
[TBL] [Abstract][Full Text] [Related]
9. Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists.
Xu C; Li M; Cai X; Yuan S; Cao J; Zhu S; Chen M; Bi N; Hu X; Li J; Zhou W; Wang P; Zhao L; Liu N
Front Oncol; 2022; 12():872324. PubMed ID: 35651806
[TBL] [Abstract][Full Text] [Related]
10. Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival.
Schreiber D; Wong AT; Schwartz D; Rineer J
J Thorac Oncol; 2015 Dec; 10(12):1770-5. PubMed ID: 26334750
[TBL] [Abstract][Full Text] [Related]
11. Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative.
Allen SG; Dragovic AF; Yin HM; Bryant AK; Paximadis PA; Matuszak MM; Schipper MJ; Dess RT; Hayman JA; Dominello MM; Kestin LL; Movsas B; Jolly S; Bergsma DP;
Pract Radiat Oncol; 2023; 13(5):444-453. PubMed ID: 37100388
[TBL] [Abstract][Full Text] [Related]
12. Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report.
Hasan S; White R; Renz P; Abel S; Otaibi Z; Monga D; Colonias A; Wegner RE
Radiother Oncol; 2019 Mar; 132():23-26. PubMed ID: 30825965
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer.
Luo J; Song J; Xiao L; Zhang J; Cao Y; Wang J; Wang P; Zhao L; Liu N
Cancer Biol Med; 2023 Jun; 20(6):452-64. PubMed ID: 37300284
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation model for limited-stage small-cell lung cancer.
Arvidson NB; Khuntia D; Tomé WA
Radiother Oncol; 2009 Jun; 91(3):379-85. PubMed ID: 19187993
[TBL] [Abstract][Full Text] [Related]
15. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775
[TBL] [Abstract][Full Text] [Related]
16. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
17. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy in small cell lung cancer: a national Italian survey.
Ciammella P; Timon G; Bruni A; Franceschini D; Borghetti P; Giaj-Levra N; Greco C; Scotti V; Trovo M;
Radiol Med; 2018 Jul; 123(7):554-560. PubMed ID: 29536412
[TBL] [Abstract][Full Text] [Related]
19. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer.
Li-Ming X; Zhao LJ; Simone CB; Cheng C; Kang M; Wang X; Gong LL; Pang QS; Wang J; Yuan ZY; Wang P
Radiother Oncol; 2017 Nov; 125(2):331-337. PubMed ID: 29079309
[TBL] [Abstract][Full Text] [Related]
20. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis.
Hasan S; Renz P; Turrisi A; Colonias A; Finley G; Wegner RE
Lung Cancer; 2018 Oct; 124():283-290. PubMed ID: 30268474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
